Beyond Celiac is the leading trusted resource on celiac disease. We are available and qualified to speak to the press on a variety of topics including, but not limited to:
Celiac disease as a serious genetic autoimmune disease
Health equity in celiac disease
Celiac disease patient advocacy and patient stories
The need for treatments beyond the gluten-free diet
The latest in celiac disease research/science/drug development
Non-GI symptoms of celiac disease
Connection to other autoimmune diseases
Growth of the gluten-free market, gluten-free labeling
If you are a member of the media, such as a journalist, blogger, etc., and want to know more about Beyond Celiac, including our research program, Science Plan, patient stories, and more, please contact Angela Crist at [email protected].
For more information on Beyond Celiac, celiac disease and the gluten-free diet:
About Beyond Celiac
Download CEO Alice Bast’s Headshots
Beyond Celiac Brand Elements/Logos
Beyond Celiac Science Plan
Download the Gluten-Free Diet Handout
Download What is Celiac Disease?
Voices of Celiac Disease Patient Stories
Fast Facts about Celiac Disease
Beyond Celiac, the leading nonprofit catalyst for a cure for celiac disease, today announced its partnership with the American Gastroenterological Association (AGA) to establish the AGA–Beyond Celiac Pilot Research Award in Celiac Disease.
Beyond Celiac, the leading catalyst for a celiac disease cure, today announced that Mary Kate Carofano has been promoted from Chief Operating Officer to President of the national non-profit organization. Carofano will work in partnership with Founder and CEO Alice Bast to set the overall vision and develop the strategic imperatives of Beyond Celiac.
This Halloween, don’t let the gluten ghouls get you down. Beyond Celiac, the leading catalyst for a celiac disease cure, has a gluten-free candy guide to help those with celiac disease or gluten sensitivity navigate the candy-filled holiday safely.
Beyond Celiac, the leading catalyst for a celiac disease cure, today celebrates National Celiac Awareness Day, a reminder of the progress made in research and the ongoing need for a cure. Beyond Celiac is driving the search for a cure by 2030 so that the 3.2 million children and adults diagnosed with the disease can live healthy lives and eat without fear of gluten exposure.
The Beyond Celiac Coalition, a precompetitive partnership of multidisciplinary stakeholders involved in the development of potential treatments for celiac disease, met recently with the FDA to discuss a collaborative approach to making therapeutic trials for celiac disease more patient-centric while maintaining scientific rigor.
Only 14% of American parents with a child under 18 understand that many kids with celiac disease do not have stomach issues, according to a nationwide survey conducted online among 2,074 U.S. adults January 9-11, 2024, by The Harris Poll on behalf of Beyond Celiac, the leading catalyst for a celiac disease cure. The survey also found nearly one-third (32%) of American parents with a child under 18 mistakenly believe that a little bit of gluten won’t hurt a child with celiac disease.
Beyond Celiac, the leading catalyst for a cure for celiac disease, today announces the creation of Beyond Celiac Investments (BCI), an investment program to accelerate the development of treatments and a cure for celiac disease by leveraging the speed and scale of venture capital and capital markets.
“Just before his third birthday, Max had dropped so much weight that he was back to wearing his one-year-old clothes.”
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to